Coherus Oncology, Inc.
CHRS
$1.42
$0.000.00%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -2.95% | -10.19% | -19.35% | 188.36% | -34.59% |
| Total Receivables | 22.22% | -92.65% | 109.38% | 91.62% | -48.96% |
| Inventory | 52.11% | 54.88% | -54.62% | 28.28% | -16.38% |
| Prepaid Expenses | -10.31% | -22.43% | -9.06% | -19.36% | 35.34% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | 92.54% |
| Total Current Assets | -0.32% | -55.16% | 21.24% | 22.58% | -9.19% |
|
|
|||||
| Total Current Assets | -0.32% | -55.16% | 21.24% | 22.58% | -9.19% |
| Net Property, Plant & Equipment | -74.55% | 163.20% | -14.37% | -15.47% | -68.20% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -1.35% | -6.56% | -5.41% | -1.26% | -1.24% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1,107.18% | -75.26% | -11.77% | -10.89% | -87.76% |
| Total Assets | 2.97% | -49.98% | 17.53% | 18.43% | -17.27% |
|
|
|||||
| Total Accounts Payable | 15.77% | -60.17% | -33.83% | -8.08% | 43.84% |
| Total Accrued Expenses | -9.80% | -30.67% | -23.74% | -35.33% | -18.09% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 3.88% | 2.07% | 1.99% | -2.17% | -36.77% |
| Total Finance Division Other Current Liabilities | -5.32% | -74.37% | 144.14% | 294.59% | 6.94% |
| Total Other Current Liabilities | -5.32% | -74.37% | 144.14% | 294.59% | 6.94% |
| Total Current Liabilities | -5.74% | -62.29% | 41.22% | 3.37% | -9.87% |
|
|
|||||
| Total Current Liabilities | -5.74% | -62.29% | 41.22% | 3.37% | -9.87% |
| Long-Term Debt | 0.86% | 0.98% | 1.23% | -83.05% | 0.80% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -34.52% | -25.13% | -19.12% | -15.70% | -13.15% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -41.14% | 12.45% | 7.84% | 103.36% | 3.06% |
| Total Liabilities | -5.03% | -53.98% | 34.13% | -42.36% | -4.48% |
|
|
|||||
| Common Stock & APIC | 3.88% | 0.76% | 0.24% | 0.39% | 0.36% |
| Retained Earnings | -2.77% | -2.80% | -2.71% | 18.52% | -3.65% |
| Treasury Stock & Other | -37.44% | 3.94% | 26.18% | 0.00% | 0.00% |
| Total Common Equity | 28.86% | -30.49% | -26.75% | 165.31% | -39.00% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 28.86% | -30.49% | -26.75% | 165.31% | -39.00% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 28.86% | -30.49% | -26.75% | 165.31% | -39.00% |
|
|
|||||